EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Greif, Inc.
GEF

GEF Greif, Inc.

Greif, Inc. · NYSE
Market Closed
82.32
▼ ⁦-1.58%⁩ (-1.32)
Market Cap$3.9B
Beta0.77
52w Low52w High
55.7590.57
Last Week
⁦-3.80%⁩
Last Month
⁦-5.82%⁩
Last 3 Months
⁦+31.92%⁩
Last Year
⁦+22.87%⁩
EL7 Factor Analysis
How we score this
Overall78
Strong — clearly above market medianTurnaroundF 5/8Better than 78% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
66
4.7x▲17.8xTop tier
▸
Growth
53
-30.6%▼7.1%Around median
▸
Quality
45
4.9%▲4.5%Around median
▸
Safety
43
—2.6xAround median
▸
Capital Return
51
—2.12%Around median
▸
Momentum
89
34.7%▲2.9%Top tier
▸
Sentiment
85
6▲3Top tier
Fair Value
Low confidenceCurrent price$82
Analyst target · 4 analysts
$86
⁦+4%⁩
See it fairly priced
Range ⁦$74–$97⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 4 analysts setting price target
$85.50
⁦+3.9%⁩
Current Price $82.32·Median $85.50
Low
$74.00
High
$97.00
Current price
$82.32
Average target
$85.50
Street summary

Consensus Stability Amid Broader Analyst Coverage

The consensus price target remained unchanged at 85.5 over one day, seven days, and 30 days, despite the number of analysts increasing from 2 to 4 over 30 days, and from 3 to 4 over the two shorter periods. This means that broader coverage did not change the average outlook, while the current range is between 74 and 97, reflecting notable divergence in estimates compared with the current price of 83.64.

As of 2026-09-10
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 2.83
Hold
Analyst coverage
⁦6 (+1)⁩
New coverage
Buy conviction
17%
Target dispersion
28%
Analyst ratings over time6 analysts rating
1
4
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.17 → 2.83
Recent analyst moves
  • = Reiterate2026-05-04
    Truist Securities
    —· $78.00
  • = Reiterate2026-01-29
    Robert W. Baird
    —· $75.00
  • = Reiterate2026-01-06
    Wells Fargo
    —· $72.00
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    4.68x
    4.56x36.49x
    Very cheap
  • Forward P/E
    17.35x
    3.79x30.29x
    Near median
  • EV / EBITDA
    —
    —
  • FCF Yield
    -4.8%
    -30.9%16.2%
    Above average
  • Revenue Growth YoY
    -30.6%
    -13.8%31.9%
    Weak
  • EPS Growth YoY
    537.7%
    -156.9%135.6%
    Exceptional
  • Gross Margin
    22.8%
    12.0%66.5%
    Below average
  • ROIC
    4.9%
    -23.8%21.5%
    Above average
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-29 data

Company Overview

Greif operates in industrial packaging solutions across four segments: Polymer Solutions, Metal Solutions, Fiber Solutions, and Closures. The company sells polymer containers, including intermediate bulk containers and small containers, alongside fiber products such as partitions, tubes, and cores, while relying on technologically advanced closures to win new customers. In the third quarter of fiscal 2026, the company specifically targeted the flavors, fragrances, and pharmaceuticals markets, while the Envaplast acquisition expanded its presence in small polymer containers in Spain and the agrochemicals market in Europe, the Middle East, and Africa.

In the third quarter of fiscal 2026, sales remained approximately level with the comparable period, but adjusted earnings before interest, taxes, depreciation, and amortization increased by about 25%, with the margin expanding by more than 260 basis points year over year and by about 110 basis points compared with the second quarter of fiscal 2026. Adjusted earnings per share also improved by about 90% year over year, and adjusted free cash flow reached $58 million, driven by an improved price-cost relationship, structural cost reductions, and lower quarterly interest and tax expenses compared with the prior period.

The performance mix was varied in the third quarter of fiscal 2026: Polymer Solutions volumes increased 1.5%, and gross profit improved in both value and margin, while Metal Solutions gross profit also improved. Closures achieved mid-single-digit growth in third-party demand and high-single-digit growth in total volumes. By contrast, Fiber Solutions sales declined year over year because of the Los Angeles plant closure, and segment margins fell due to cost inflation. For historical comparison only, the latest filed EDGAR statements, which are for the second quarter of fiscal 2018, show revenue of $968.3 million, gross profit of $195.3 million, and net income of $45.1 million, equivalent to a gross margin of approximately 20.2% and a net income margin of approximately 4.7%.

What's Driving the Stock

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

Greif raised its adjusted earnings before interest, taxes, depreciation, and amortization guidance range for fiscal 2026 to $615–635 million, compared with a previous assumption at the low end of $610 million, representing expected annual growth of between 10% and 13% despite including an impact of about $20 million related to the Middle East conflict.
  • Structural cost reductions reached an annualized rate of $90 million ahead of schedule, and management is targeting an annualized rate of $120 million by the end of fiscal 2027. Together with improved pricing relative to costs, this helped raise adjusted earnings before interest, taxes, depreciation, and amortization by about 25% in the third quarter of fiscal 2026.
  • Polymer Solutions volumes increased 1.5% in the third quarter of fiscal 2026, led by intermediate bulk containers and large polymer containers. The Envaplast acquisition provides a foothold in Spain for expansion in small containers and the agrochemicals market, with management stating that Envaplast’s earnings before interest, taxes, depreciation, and amortization margins exceed 18% and that its free cash flow conversion exceeds 50%.
  • Closures achieved mid-single-digit growth in third-party demand and high-single-digit growth in total volumes during the third quarter of fiscal 2026, supported by price and product mix, new customers, and cost reductions. At the same time, Greif restructured its commercial organization and launched Greif+ to serve existing customers, allowing the sales team to devote more time to acquiring new customers.
  • Greif expects adjusted free cash flow of between $305 million and $325 million in fiscal 2026, equivalent to conversion of approximately 50%, after recording $58 million in the third quarter of fiscal 2026. With leverage of 1.1 times, the company completed a $150 million share repurchase program, increased its regular dividend by 10.7%, and requested authorization for an additional $150 million share repurchase program.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +Greif demonstrated its ability to expand profitability without relying on a market recovery. Sales in the third quarter of fiscal 2026 were nearly flat year over year, while adjusted earnings before interest, taxes, depreciation, and amortization increased by about 25%, and the margin expanded by more than 260 basis points.
    • +Achieving $90 million in annualized cost reductions ahead of schedule, with a target of $120 million by the end of fiscal 2027, provides a defined path to higher earnings and margins even if industrial demand remains uneven.
    • +The financial position combines low leverage of 1.1 times with expected adjusted free cash flow of between $305 million and $325 million in fiscal 2026, supporting organic investment, additional acquisitions, dividends, and share repurchases without exceeding management’s target of keeping leverage below 2 times.
    • +Envaplast gives the company a presence in small polymer containers in Spain and the agrochemicals market, while the customer acquisition strategy focuses on flavors, fragrances, and pharmaceuticals. These are specific markets that support growth diversification away from a broad cyclical recovery.

    ▼ Selling Case6 pts

    • −Underlying demand remains weak and uneven. Management said that the global improvement in the third quarter of fiscal 2026 began from a very low base and declined to characterize it as an inflection point, while broader industrial markets remained weak and chemicals and housing markets stayed at historically low levels for the fiber and steel businesses.
    • −Fiber Solutions experienced a year-over-year decline in sales because of the Los Angeles plant closure and lower margins due to cost inflation, while the RISI index had not reflected the second price increase of $60 per ton by the time of the call. The company implemented the increase for customers not tied to the index but did not include RISI recognition of it in its guidance, leaving the segment’s margin recovery exposed to pricing and cost risks.
    • −Middle East disruptions caused an expected impact of about $20 million during fiscal 2026 and led Greif to hold higher-than-normal inventory at elevated cost to ensure continuity of supply. Although inventory quantity and cost are expected to decline in the fourth quarter of fiscal 2026, management said that part of the impact from higher indices would continue through the end of the fiscal year.
    • −The fiscal 2026 adjusted free cash flow range of $305–325 million includes higher working capital assumptions and restructuring costs compared with the previous guidance, only partially offset by improved cash taxes. Therefore, achieving cash conversion of approximately 50% depends on the normalization of inventory and costs during the fourth quarter of fiscal 2026.
    • −Greif intends to complete several additional acquisitions similar to Envaplast annually, adding recurring risks related to acquisition price, execution, and integration, even as management emphasizes that it is targeting small bolt-on transactions rather than transformative acquisitions.
    • −Analyst consensus reflects a Neutral rating, while their targets range from $74 to $97. This $23 spread indicates material uncertainty about the value of margin improvements relative to persistent demand weakness. The average target of $85.5 is about 5.6% below the 52-week range high of $90.57, limiting the strength of the re-rating case if the expected earnings growth does not materialize.

    Valuation

    Analyst consensus on Greif is Neutral, with an average target of $85.5 and a wide range between $74 and $97. The average target falls within the 52-week range of $55.75–90.57, and the lowest target is also within it, while the highest target exceeds the top of the range. This reflects a divide between the value of the fiscal 2026 guidance increase and margin improvement on one hand, and weak demand and risks related to fiber and working capital on the other. The available data do not include a valid earnings multiple that can be used to confirm whether the valuation is low or high on an earnings basis.

    HoldAnalyst target: $85.5(+3.9%)

    Figures in the text are as of 2026-08-31; the live price is shown at the top of the page.

    FAQ

    What drove Greif’s earnings growth in the third quarter of fiscal 2026 despite stable sales?

    Sales remained approximately level with the comparable period, but adjusted earnings before interest, taxes, depreciation, and amortization increased by about 25%. The improvement came primarily from a better price-cost relationship and structural cost reductions, expanding the margin by more than 260 basis points year over year and 110 basis points compared with the second quarter of fiscal 2026. Lower quarterly interest and tax expenses compared with the prior period also contributed to an approximately 90% increase in adjusted earnings per share.

    What are Greif’s earnings and cash flow expectations for fiscal 2026?

    The company raised its adjusted earnings before interest, taxes, depreciation, and amortization range to $615–635 million, equivalent to expected annual growth of between 10% and 13%. The range includes an expected impact of about $20 million related to the Middle East conflict. Greif expects adjusted free cash flow of between $305 million and $325 million and cash conversion of approximately 50%, despite higher working capital assumptions and restructuring costs.

    How does the Envaplast acquisition affect Greif’s growth strategy?

    Envaplast gives Greif a stronger presence in the small polymer container market in Spain, where its presence was previously limited. It also expands its exposure to the agrochemicals market, which represents the majority of Envaplast’s business, and supports its growth strategy in Europe, the Middle East, and Africa. According to the transaction criteria presented by management on July 29, 2026, Envaplast’s earnings before interest, taxes, depreciation, and amortization margins exceed 18%, and its free cash flow conversion exceeds 50%, while Greif plans to continue pursuing similar small bolt-on acquisitions.

    What is the main problem facing Greif’s Fiber Solutions segment?

    Fiber Solutions sales declined year over year in the third quarter of fiscal 2026 because of the Los Angeles plant closure, while margins also fell due to cost inflation. A $60 per ton price increase announced in April 2026 began to appear in the results, and the company then announced an additional increase of the same amount in June 2026 and fully implemented it for customers not tied to the RISI index. The index had not recognized the second increase by the time of the July 29, 2026 call, despite plant operating rates reaching 96% and management indicating healthy demand.

    How is Greif allocating capital after the improvement in earnings?

    Leverage was 1.1 times in the third quarter of fiscal 2026, and management intends to keep the ratio below 2 times, while viewing a level below 1.5 times as more realistic in the near term. The company completed a $150 million share repurchase program earlier in fiscal 2026 and increased its regular dividend by 10.7%. It also asked the board’s share repurchase committee to authorize an additional $150 million program, alongside organic investment and small bolt-on acquisitions.

    What could change analysts’ Neutral view of GEF shares?

    A positive view could be supported by Greif’s ability to achieve its adjusted earnings before interest, taxes, depreciation, and amortization range of $615–635 million and adjusted free cash flow range of $305–325 million in fiscal 2026. Reaching annualized cost reductions of $120 million by the end of fiscal 2027, alongside continued growth in Polymer Solutions and Closures, would provide further evidence of strong structural improvement. By contrast, weak industrial markets, declining Fiber Solutions margins, and elevated working capital could keep the consensus at Neutral, consistent with the wide target range between $74 and $97.